Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Prognostic Impact of Morphology, MYC Gene Partner and BCL2/BCL6 Translocation Status in "High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements"

Ellen D. McPhail, MD, Matthew J Maurer, MS, Rhett P. Ketterling, MD, William R. Macon, MD, Andrew L Feldman, MD, Paul J Kurtin, MD, Thomas E. Witzig, MD, Rakhee Vaidya, MD, Thomas M. Habermann, MD

Blood (2016) 128 (22): 1750.

https://doi.org/10.1182/blood.V128.22.1750.1750

Published: 2016

Journal Articles

Treatment and Clinical Outcomes of High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements (Double Hit/Triple Hit Lymphomas)

Thomas M. Habermann, MD, William R. Macon, MD, Matthew J Maurer, MS, Rhett P. Ketterling, MD, Paul J Kurtin, MD, Andrew L Feldman, MD, Rakhee Vaidya, MD, James R Cerhan, MD PhD, Stephen Ansell, MD PhD, Luis Porrata, MD, Grzegorz S. Nowakowski, MD, Thomas E. Witzig, MD, Ellen D. McPhail, MD

Blood (2016) 128 (22): 155.

https://doi.org/10.1182/blood.V128.22.155.155

Published: 2016

Journal Articles

Phase I Dose-Escalation Study of Cpi-613, in Combination with Bendamustine, in Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

Zanetta S. Lamar, MD, Scott Isom, MS, Rakhee Vaidya, MD, Anne W Beaven, MD, Zachariah A. McIver, DO

Blood (2016) 128 (22): 4163.

https://doi.org/10.1182/blood.V128.22.4163.4163

Published: 2016

Journal Articles

Risk Factors for Thrombosis Among 1,545 Patients with Polycythemia Vera: An International Study.

Guido Finazzi, MD, Elisa Rumi, MD, Alessandro M. Vannucchi, MD, Maria Luigia Randi, Ilaria Nichele, Heinz Gisslinger, MD, Rakhee Vaidya, MD, Mario Cazzola, Alessandro Rambaldi, MD, Lisa Pieri, MD, Francesco Rodeghiero, MD, Animesh Pardanani, MBBS, PhD, Juergen Thiele, Francesco Passamonti, MD, T Barbui, Ayalew Tefferi, MD

Blood (2012) 120 (21): 2849.

https://doi.org/10.1182/blood.V120.21.2849.2849

Published: 2012

Journal Articles

Comprehensive Plasma Cytokine Profiling in Polycythemia Vera: Comparison with Myelofibrosis and Clinical Correlates,

Rakhee Vaidya, MD, Nanna Sulai, Shaina A Rozell, MD, Sania S Raza, MD, Sameer Parikh, MD, Thitina Jimma, MD, Christy Finke, BS, Terra L Lasho, MT, (ASCP), Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2011) 118 (21): 3850.

https://doi.org/10.1182/blood.V118.21.3850.3850

Published: 2011

Journal Articles

Predictors of Greater Than 80% Two-Year Mortality in Primary Myelofibrosis: A Mayo Clinic Study of 884 Karyotypically-Annotated Cases

Ayalew Tefferi, MD, Naseema Gangat, MD, Rakhee Vaidya, MD, Kebede Begna, MD, Curtis A. Hanson, MD, Daniel L. Van Dyke, Ph.D., Domenica Caramazza, Animesh Pardanani, MBBS, PhD

Blood (2011) 118 (21): 2806.

https://doi.org/10.1182/blood.V118.21.2806.2806

Published: 2011

Journal Articles

Survival and Prognosis Among 1,263 Patients with Polycythemia Vera: An International Study

Ayalew Tefferi, MD, Elisa Rumi, Guido Finazzi, MD, Alessandro M. Vannucchi, MD, Maria Luigia Randi, Ilaria Nichele, Heinz Gisslinger, MD, Rakhee Vaidya, MD, Mario Cazzola, Alessandro Rambaldi, Lisa Pieri, MD, Francesco Rodeghiero, MD, Irene Bertozzi, Bettina Gisslinger, Animesh Pardanani, MBBS, PhD, Juergen Thiele, Francesco Passamonti, MD, Tiziano Barbui, MD

Blood (2011) 118 (21): 277.

https://doi.org/10.1182/blood.V118.21.277.277

Published: 2011

NARROW

Prognostic Impact of Morphology, MYC Gene Partner and BCL2/BCL6 Translocation Status in "High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements"

Treatment and Clinical Outcomes of High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements (Double Hit/Triple Hit Lymphomas)

Phase I Dose-Escalation Study of Cpi-613, in Combination with Bendamustine, in Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

Risk Factors for Thrombosis Among 1,545 Patients with Polycythemia Vera: An International Study.

Comprehensive Plasma Cytokine Profiling in Polycythemia Vera: Comparison with Myelofibrosis and Clinical Correlates,

Predictors of Greater Than 80% Two-Year Mortality in Primary Myelofibrosis: A Mayo Clinic Study of 884 Karyotypically-Annotated Cases

Survival and Prognosis Among 1,263 Patients with Polycythemia Vera: An International Study

Email alerts

ASH Publications

American Society of Hematology

Prognostic Impact of Morphology, MYC Gene Partner and BCL2/BCL6 Translocation Status in "High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements"

Treatment and Clinical Outcomes of High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements (Double Hit/Triple Hit Lymphomas)

Phase I Dose-Escalation Study of Cpi-613, in Combination with Bendamustine, in Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

Risk Factors for Thrombosis Among 1,545 Patients with Polycythemia Vera: An International Study.

Comprehensive Plasma Cytokine Profiling in Polycythemia Vera: Comparison with Myelofibrosis and Clinical Correlates,

Predictors of Greater Than 80% Two-Year Mortality in Primary Myelofibrosis: A Mayo Clinic Study of 884 Karyotypically-Annotated Cases

Survival and Prognosis Among 1,263 Patients with Polycythemia Vera: An International Study

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only